Skip to main content
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 1986 Apr;50(2):154–164.

The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.

R F Carter, V E Valli, J H Lumsden
PMCID: PMC1255183  PMID: 3756669

Abstract

No significance has been shown yet between the cytological subtypes of canine lymphoma and clinical behaviour. This paper describes and illustrates the cytological and histological criteria for application of the National Cancer Institute Working Formulation classification system, a scheme with demonstrated prognostic capability for human non-Hodgkin's lymphomas, to a series of 285 canine lymphomas. The Working Formulation can be used without difficulty for canine lymphomas. Low grade follicular tumors were found to be much less common, and high grade, aggressive tumors much more common than these cell types in humans. Low grade tumors tend to have low mitotic rates and high grade tumors tend to have high mitotic rates. There may be an association between hypercalcemia and lymphoblastic cell type. A review of available literature data for canine lymphomas suggests that prognostic extrapolation of clinical behaviour based on human lymphoma data may be possible. These results suggest that there may be strong similarities of morphology and behaviour between human non-Hodgkin's lymphomas and canine lymphomas.

Full text

PDF
154

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum F. R., Sale G. E., Storb R., Charrier K., Deeg H. J., Graham T., Wulff J. C. Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy. Hematol Oncol. 1984 Apr-Jun;2(2):151–168. doi: 10.1002/hon.2900020205. [DOI] [PubMed] [Google Scholar]
  2. Calvert C. A., Leifer C. E. Doxorubicin for treatment of canine lymphosarcoma after development of resistance to combination chemotherapy. J Am Vet Med Assoc. 1981 Nov 15;179(10):1011–1012. [PubMed] [Google Scholar]
  3. Gaynor E. R., Ultmann J. E. Non-Hodgkin's lymphoma: management strategies. N Engl J Med. 1984 Dec 6;311(23):1506–1508. doi: 10.1056/NEJM198412063112309. [DOI] [PubMed] [Google Scholar]
  4. Gray K. N., Raulston G. L., Gleiser C. A., Jardine J. H. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs. J Am Vet Med Assoc. 1984 Apr 1;184(7):814–817. [PubMed] [Google Scholar]
  5. Holmberg C. A., Manning J. S., Osburn B. I. Canine malignant lymphomas: comparison of morphologic and immunologic parameters. J Natl Cancer Inst. 1976 Jan;56(1):125–135. doi: 10.1093/jnci/56.1.125. [DOI] [PubMed] [Google Scholar]
  6. Honegger H. P., Cavalli F. Current status and perspectives in the treatment of non-Hodgkin's lymphomas. Eur J Cancer Clin Oncol. 1984 Mar;20(3):305–314. doi: 10.1016/0277-5379(84)90074-9. [DOI] [PubMed] [Google Scholar]
  7. Horning S. J., Rosenberg S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med. 1984 Dec 6;311(23):1471–1475. doi: 10.1056/NEJM198412063112303. [DOI] [PubMed] [Google Scholar]
  8. MacEwen E. G., Brown N. O., Patnaik A. K., Hayes A. A., Passe S. Cyclic combination chemotherapy of canine lymphosarcoma. J Am Vet Med Assoc. 1981 Jun 1;178(11):1178–1181. [PubMed] [Google Scholar]
  9. Madewell B. R. Chemotherapy for canine lymphosarcoma. Am J Vet Res. 1975 Oct;36(10):1525–1528. [PubMed] [Google Scholar]
  10. Meuten D. J., Kociba G. J., Capen C. C., Chew D. J., Segre G. V., Levine L., Tashjian A. H., Jr, Voelkel E. F., Nagode L. A. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations. Lab Invest. 1983 Nov;49(5):553–562. [PubMed] [Google Scholar]
  11. Moir D. H. War of the words: classification of non-Hodgkin's lymphomas. Pathology. 1983 Oct;15(4):359–360. doi: 10.3109/00313028309085157. [DOI] [PubMed] [Google Scholar]
  12. Monfardini S., Rilke F., Valagussa P., Bajetta E., Canetta R., Buzzoni R., Giardini R., Viviani S. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications. Eur J Cancer Clin Oncol. 1984 May;20(5):609–617. doi: 10.1016/0277-5379(84)90005-1. [DOI] [PubMed] [Google Scholar]
  13. Osbaldiston G. W., Sullivan R. J. Cytochemical demonstration of esterases in peripheral blood leukocytes. Am J Vet Res. 1978 Apr;39(4):683–685. [PubMed] [Google Scholar]
  14. Percy C., O'Conor G., Ries L. G., Jaffe E. S. Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation. Cancer. 1984 Oct 1;54(7):1435–1438. doi: 10.1002/1097-0142(19841001)54:7<1435::aid-cncr2820540734>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  15. Smith B. R., Weinberg D. S., Robert N. J., Towle M., Luther E., Pinkus G. S., Ault K. A. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma. N Engl J Med. 1984 Dec 6;311(23):1476–1481. doi: 10.1056/NEJM198412063112304. [DOI] [PubMed] [Google Scholar]
  16. Squire R. A., Bush M., Melby E. C., Neeley L. M., Yarbrough B. Clinical and pathologic study of canine lymphoma: clinical staging, cell classification, and therapy. J Natl Cancer Inst. 1973 Aug;51(2):565–574. [PubMed] [Google Scholar]
  17. Tindle B. H. Malignant lymphomas. Am J Pathol. 1984 Jul;116(1):119–174. [PMC free article] [PubMed] [Google Scholar]
  18. Valli V. E., McSherry B. J., Dunham B. M., Jacobs R. M., Lumsden J. H. Histocytology of lymphoid tumors in the dog, cat and cow. Vet Pathol. 1981 Jul;18(4):494–512. doi: 10.1177/030098588101800408. [DOI] [PubMed] [Google Scholar]
  19. Weller R. E., Holmberg C. A., Theilen G. H., Madewell B. R. Histologic classification as a prognostic criterion for canine lymphosarcoma. Am J Vet Res. 1980 Aug;41(8):1310–1314. [PubMed] [Google Scholar]
  20. Weller R. E., Theilen G. H., Madewell B. R., Crow S. E., Benjamini E., Villalobos A. Chemoimmunotherapy for canine lymphosarcoma: a prospective evaluation of specific and nonspecific immunomodulation. Am J Vet Res. 1980 Apr;41(4):516–521. [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES